|
|
Article: Tests to start on implanted device for hypertension; An alternative treatment for reducing high blood pressure is about to begin clinical trials in the United States.(BUSINESS)
- Article from:
- Star Tribune (Minneapolis, MN)
- Article date:
- October 17, 2006
- Author:
CopyrightCOPYRIGHT 2006 Star Tribune Co. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Janet Moore; Staff Writer
A Maple Grove company received regulatory approval Monday to begin U.S. clinical trials on a device that could offer a new way to treat high blood pressure.
Privately held CVRx Inc. will evaluate the safety and effectiveness of its Rheos Baroreflex Hypertension Therapy System - a pacemaker-like device that uses electrical stimulation to treat the condition. Data from the blind study, which will involve 40 medical centers, will be used to bolster the company's application with the Food and Drug Administration for the device's introduction in the U.S. market.
High blood pressure, also known as hypertension, ...